Intravitreal topotecan: Clinical Trials

2 trials of Intravitreal topotecan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Recruiting 1

Follow Intravitreal topotecan: new trials by email Literature Review of Intravitreal topotecan trials Research Report on Intravitreal topotecan

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravitreal Topotecan for Prevention or Treatment of Proliferative Vitreoretinopathy in Retinal Detachment
Intravitreal topotecan, Retinal detachment surgery - Retinal Detachment Rhegmatogenous, Proliferative Vitreoretinopathy
Phase 2Not yet recruitingUnity Health Toronto3942025-03-012025-03-06
Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy
Intravitreal topotecan, Pars plana vitrectomy with or without scleral buckle - Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
Phase 2RecruitingUnity Health Toronto502023-02-232025-02-11

Conditions studied

Vitreoretinopathy, Proliferative (1)

Sponsors

Unity Health Toronto (2)

Countries

Canada (2)